Articles from Proscia

Compliance with independent security standards comes as Proscia accelerates digital pathology deployments at scale

Proscia®, a leader in digital and computational pathology solutions, today announced that its Concentriq® Dx platform has been certified under the new In Vitro Diagnostic Regulation (IVDR) for use in primary diagnosis. This certification will enable the company’s continued growth in the European diagnostic pathology market, where it is helping leading laboratories to modernize their routine operations.

Proscia®, a leader in digital and computational pathology solutions, today announced that it has been awarded a U.S. General Service Administration’s (GSA) Multiple Award Schedule (MAS). This five-year contract provides government agencies with streamlined access to the company’s Concentriq® platform, helping them to accelerate adoption of digital pathology. Concentriq is available under contract #47QTCA22D0089.

Proscia®, a leader in digital and computational pathology solutions, has introduced an automated quality control application that leverages artificial intelligence to improve quality and efficiency in data-driven drug development. In launching automated quality control, Proscia is delivering on digital pathology’s first suite of process automation solutions, streamlining manual, repetitive tasks with AI. The company has also released a new version of its Concentriq® for Research platform to further unify global pathology operations and centralize data across the connected enterprise.

Proscia®, a leader in digital and computational pathology solutions, and Visiopharm, a world leader in AI-driven precision pathology software, today announced a strategic partnership to deliver integrated AI-enabled solutions that aim to improve clinical decision making for cancer care. Through the collaboration, the partners will advance the use of AI-enabled solutions to deliver new insights to pathologists for two of the most common cancer diagnoses.

Proscia®, the leader in digital and computational pathology solutions, today announced a multi-year OEM agreement with Siemens Healthineers. Under the agreement, Siemens Healthineers will expand its Enterprise Imaging offering towards the global digital pathology market using Proscia’s Concentriq® Dx platform.

Proscia®, the leader in digital and computational pathology solutions, and Uppsala University Hospital, Sweden’s oldest university hospital, today announced a multi-year agreement to fully digitize the region’s pathology workflows. The division of Laboratory Medicine at Uppsala University Hospital has selected Proscia’s Concentriq Dx® digital pathology solution for full-scale digitization and future deployment of AI applications in routine operations at scale, empowering the region’s pathologists to drive increased quality and productivity gains and unlock hidden insights to better inform patient care.

Proscia®, a leading provider of digital and computational pathology solutions, has released study results on new technology that leverages artificial intelligence (AI) to automatically detect melanoma, the deadliest form of skin cancer, with a high degree of accuracy. The findings illustrate the promise of AI to deliver faster diagnoses, improve patient outcomes, and optimize laboratory economics in the routine practice of pathology.

Proscia®, a leading provider of digital and computational pathology solutions, has introduced the next generation of its flagship Concentriq® platform to help the world’s largest laboratory networks keep pace with the growing need for diagnostic services in the post-COVID era. The latest version, which will be unveiled during the virtual “Future Ready Pathology” event on June 15th, delivers performance, functionality, and design enhancements that drive meaningful quality and efficiency gains in routine pathology diagnosis for multi-site and remote operations.

Proscia®, a leading provider of digital and computational pathology solutions, today announces Future Ready Pathology, an industry event for helping diagnostic laboratories rapidly modernize in the post-pandemic era and beyond. The virtual event, scheduled for June 15, 2021, will feature informative sessions, panel discussions, and insights from digital health and laboratory pioneers, including former FDA commissioner Dr. Scott Gottlieb. It will also showcase technologies driving the industry forward with the introduction of major upgrades to the Concentriq® digital pathology platform.